Abstract

http://ssrn.com/abstract=1407522
 
 

Citations (1)



 
 

Footnotes (109)



 


 



Disease-Based Limitations on Compulsory Licenses Under Articles 31 and 31bis


Kevin Outterson


Boston University School of Law

May 20, 2009

RESEARCH HANDBOOK ON INTELLECTUAL PROPERTY LAW AND THE WTO, Carlos Correa, ed., Edward Elgar, 2009
Boston Univ. School of Law Working Paper No. 09-26

Abstract:     
Compulsory licensure is one of the flexibilities retained under TRIPS to permit countries to support public health while granting pharmaceutical patents. The United States Government appears to take the position that compulsory licensure and other TRIPS flexibilities must be limited to certain infectious diseases, namely AIDS, tuberculosis, and malaria. These proposed limitations are not supported by the text of Articles 31 and 31bis of TRIPS or by the negotiating history of the Agreement. Introducing disease-based limitations would be unwise, as the developing world is undergoing a demographic transition, with increasing shares of its disease burden coming from non-infectious diseases. Public health calls for retaining TRIPS flexibilities in all categories of human need.

Number of Pages in PDF File: 22

Keywords: compulsory license, TRIPS, pharmaceuticals, USTR, disease

JEL Classification: I18, K11, K33

Accepted Paper Series


Download This Paper

Date posted: May 20, 2009  

Suggested Citation

Outterson, Kevin, Disease-Based Limitations on Compulsory Licenses Under Articles 31 and 31bis (May 20, 2009). RESEARCH HANDBOOK ON INTELLECTUAL PROPERTY LAW AND THE WTO, Carlos Correa, ed., Edward Elgar, 2009; Boston Univ. School of Law Working Paper No. 09-26. Available at SSRN: http://ssrn.com/abstract=1407522

Contact Information

Kevin Outterson (Contact Author)
Boston University School of Law ( email )
765 Commonwealth Avenue
Boston, MA 02215
United States
Feedback to SSRN


Paper statistics
Abstract Views: 728
Downloads: 154
Download Rank: 112,252
Citations:  1
Footnotes:  109

© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.  FAQ   Terms of Use   Privacy Policy   Copyright   Contact Us
This page was processed by apollo3 in 0.328 seconds